Henry E. Hockeimer, Jr.

Second Circuit Reverses Conviction Involving Off-Label Promotion

A divided panel of the Second U.S. Circuit Court of Appeals has thrown out the conviction of a pharmaceutical sales representative who marketed a narcolepsy drug for so-called off-label uses not approved by the Food and Drug...more

12/5/2012 - FDCA Off-Label Use